Structure of a serpin-enzyme complex probed by cysteine substitutions and fluorescence spectroscopy

Biophysical Journal

Volumn 80, Issue 1, 2001, Pages 491-497

  Ludeman, Justin P ^a   Whisstock, James C ^a   Hopkins, Paul C R ^b   Le Bonniec, Bernard F ^c   Bottomley, Stephen P ^a  

^a MONASH UNIVERSITY   (Australia)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; ETHYLENEDIAMINE DERIVATIVE; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN INHIBITOR; TRYPSIN INHIBITOR;

AMINO ACID SUBSTITUTION; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; COVALENT BOND; CRYSTAL STRUCTURE; ENZYME INHIBITOR COMPLEX; ENZYME STRUCTURE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL;

EID: 0035136717     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(01)76031-6     Document Type: Article

References (38)

1. Natural protein proteinase inhibitors and their interaction with proteinases
2. Antitrypsin polymerisation can occur by both loop A and C sheet mechanisms
3. Biological implications of a 3 A structure of dimeric antithrombin
4. Antichymotrypsin interaction with chymotrypsin: Partitioning of the complex
5. Fluorescence quenching studies with proteins
6. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin
7. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease
8. Effects of mutations in the hinge region of serpins
9. The contribution of the conserved hinge region residues of alpha1-antitrypsin to its reaction with elastase
10. Molecular recognition: Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors
11. Probing the unfolding pathway of antitrypsin
12. Serpin-protease complexes are trapped as stable acyl-enzyme intermediates
13. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors
14. Identification of thrombin residues that modulate its interactions with antithrombin III and alpha 1-antitrypsin
15. Solute perturbation of protein fluorescence: The quenching of the trytophyl fluorescence of model compounds and of lysozyme by iodide ion
16. Human alpha 1-proteinase inhibitor: Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function
17. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis
18. The kinetic mechanism of serpin-proteinase complex formation: An intermediate between the Michaelis complex and the inhibited complex
19. Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin
20. The serpin superfamily of proteinase inhibitors: Structure, function, and regulation
21. Structure of the hirulog 3-thrombin complex and nature of the S′ subsites of substrates and inhibitors
22. Comparative protein modelling by satisfaction of spatial restraints
23. On the size of the active site in proteases. I. Papain
24. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions
25. A fluorescent probe study of plasminogen activator inhibitor-1: Evidence for reactive center loop insertion and its role in the inhibitory mechanism
26. The 2.6 angstrom structure of antithrombin indicates a conformational change at the heparin binding site
27. What do dysfunctional serpins tell us about molecular mobility and disease?
28. Serpin tertiary structure transformation
29. Kinetics of the inhibition of thrombin by hirudin
30. Inhibitory mechanism of serpins: Identification of steps involving the active-site serine residue of the protease
31. Serpins: A mechanistic class of their own
32. Major proteinase movement upon stable serpin-proteinase complex formation
33. Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh
34. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into beta-sheet A
35. Modeling of serpin-protease complexes: Antithrombin-thrombin, alpha(1)-antitrypsin (358Met→Arg)-thrombin, alpha 1-antitrypsin (358Met→Arg)-trypsin, and antitrypsin-elastase
36. Conformational changes in serpins. I. The native and cleaved conformations of alpha(1)-antitrypsin
37. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins
38. The structural puzzle of how serpin serine proteinase inhibitors work